US FDA extends review of Applied Therapeutics' genetic disease drug-February 2024-www.financetom.com

US FDA extends review of Applied Therapeutics' genetic disease drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA extends review of Applied Therapeutics' genetic disease drug

Mar 28, 2024 2:06 PM

March 28 (Reuters) - The U.S. Food and Drug

Administration has extended its review of Applied Therapeutics' ( APLT )

experimental drug to treat galactosemia, a rare genetic

metabolic disease, the company said on Thursday.

The health regulator will now give its decision by Nov. 28,

2024, compared with its previous action date of Aug. 28.

Previous page： Update: Market Chatter: Bosch the Frontrunner to Acquire Johnson Controls' HVAC Assets Next page： --Easterly Government Properties Keeps Quarterly Dividend at $0.265 a Share, Payable Aug. 13 to Shareholders of Record Aug. 1

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Market Chatter: Bosch the Frontrunner to Acquire Johnson Controls' HVAC Assets

Jul 18, 2024

11:19 AM EDT, 07/18/2024 (MT Newswires) -- (Updates with additional details in second and third paragraphs.) Robert Bosch GmbH is the frontrunner to acquire the portfolio of heating and ventilation assets being sold by Johnson Controls International ( JCI ) , Bloomberg reported Thursday, citing people with knowledge of the matter. The companies are in advanced discussions about the terms...

--Easterly Government Properties Keeps Quarterly Dividend at $0.265 a Share, Payable Aug. 13 to Shareholders of Record Aug. 1

Jul 18, 2024

10:46 AM EDT, 07/18/2024 (MT Newswires) -- Price: 13.95, Change: +0.11, Percent Change: +0.79 ...

OpenAI unveils cheaper small AI model GPT-4o mini

Jul 18, 2024

July 18 (Reuters) - ChatGPT maker OpenAI said on Thursday it was launching GPT-4o mini, a cost-efficient small AI model, aimed at making its technology more affordable and less energy intensive, allowing the startup to target a broader pool of customers. Microsoft ( MSFT )-backed OpenAI, which is the market leader in the AI software space, has been working to...

Update: Market Chatter: Google-Backed Glance InMobi Looking to Raise $250 Million Capital in Financing Round

Jul 18, 2024

11:16 AM EDT, 07/18/2024 (MT Newswires) -- (Updates with Glance InMobi's response in the third paragraph.) Alphabet's (GOOG, GOOGL) Google ( GOOG )-backed Glance InMobi, an Indian mobile content provider, is in advanced discussions to raise as much as $250 million within a few weeks in a financing round led by Google ( GOOG ), Bloomberg reported Thursday, citing unnamed...